Salicylate poisoning is a serious complication of aspirin overdose and is characterized by mixed respiratory alkalosis and increased anion gap metabolic acidosis.
Pathophysiology
- Occurs with acute ingestion of >150 mg/kg. Doses >300 mg/kg are associated with severe toxicity, and >500 mg/kg are potentially lethal.
- Dual mechanism of acid-base disturbance:
- Respiratory Alkalosis (Early): Salicylates directly stimulate the medullary respiratory center, leading to hyperventilation and a primary respiratory alkalosis. This is the initial disturbance.
- Anion Gap Metabolic Acidosis (Later): Salicylates uncouple oxidative phosphorylation in the mitochondria. This shifts cells to anaerobic metabolism, leading to the accumulation of lactate and ketoacids, causing a primary metabolic acidosis.
- The classic picture is a mixed respiratory alkalosis and metabolic acidosis.
- In young children, metabolic acidosis may be the dominant or only initial finding.
Clinical features
- Early Symptoms: Nausea, vomiting, abdominal pain, and lethargy are common. Tinnitus (ringing in the ears) is a classic and early symptom.
- Systemic Symptoms:
- Hyperthermia/Fever: Due to uncoupling of oxidative phosphorylation, which generates heat. This is particularly common in children.
- Tachypnea: Caused by direct stimulation of the respiratory center.
- Severe Toxicity:
- Altered Mental Status: Confusion, agitation, delirium, seizures, or coma can occur, often due to low glucose levels in the brain and cerebral edema.
- Pulmonary Edema: Non-cardiogenic pulmonary edema can develop from direct lung toxicity.
- Hypoglycemia: Can occur despite normal serum glucose due to low CNS glucose levels.
Diagnostics
Differential diagnostics
Link to original
Feature Salicylate (ASA) Acetaminophen (APAP) Reye Syndrome Path Uncouple oxidative phosphorylation (leads to hyperthermia); Direct stimulation of resp center. Glutathione depletion NAPQI centrilobular hepatic necrosis. Mito dysfunction ( -oxidation) Microvesicular fatty change in liver Hx/Trigger OD; Wintergreen oil OD (esp. w/ CYP inducers/EtOH) Child + Virus + ASA Key Sx Tinnitus, Hyperthermia, Tachypnea RUQ pain, Fulminant liver failure Encephalopathy, Vomiting Labs/Path Mixed Resp Alk + Met Acidosis Zone 3 Necrosis, AST/ALT Microvesicular fatty liver, Glucose, Ammonia Tx NaHCO3 (Alkalinize urine), Dialysis N-acetylcysteine (restore glutathione) Supportive
Treatment
- 1. Supportive Care (ABCDE Approach): Stabilize airway, breathing, and circulation.
- Intravenous fluids are given for dehydration.
- Glucose (Dextrose) should be administered, even if serum glucose is normal, to address potential CNS hypoglycemia.
- Avoid intubation if possible. If necessary, hyperventilation must be maintained on the ventilator to prevent worsening acidosis, as a sudden rise in PaCO2 can be fatal.
- 2. GI Decontamination:
- Activated Charcoal: Can be given if the patient presents within 1-2 hours of ingestion to decrease absorption. Multiple doses may be considered for large or sustained-release ingestions.
- 3. Enhanced Elimination:
- IV Sodium Bicarbonate: This is the mainstay of treatment. It serves two purposes:
- Alkalinizes the urine (to a pH of 7.5-8.0), which traps the ionized form of salicylic acid in the renal tubules, enhancing its excretion.
- Alkalinizes the serum, which helps shift salicylate out of the central nervous system and into the plasma.
- Potassium supplementation is often required, as hypokalemia can prevent effective urinary alkalinization.
- IV Sodium Bicarbonate: This is the mainstay of treatment. It serves two purposes:
- 4. Hemodialysis:
- Indications: Used for severe cases and is life-saving.
- Criteria include: very high salicylate levels (>90-100 mg/dL), end-organ damage (e.g., seizures, cerebral edema, renal failure, pulmonary edema), severe acidosis (pH < 7.2), or failure of standard therapy.